SUBSCRIBE BY RSS rss feed | EMAIL
Natural Solutions Radio header image

ADD / ADHD

FDA calls for new warnings on ADHD drugs

Aug 21, 2006

WASHINGTON - Several drugs to treat attention deficit hyperactivity disorder must include new warning information about the risk of heart problems and psychotic behavior, U.S. health officials said on Monday.

The drugs, which include GlaxoSmithKline Plc's Dexedrine and Novartis AG's Ritalin, must include a warning about the possible risk of sudden death and serious heart problems, Food and Drug Administration spokeswoman Susan Bro told Reuters.

Topics: 

Study: ADHD Drugs Send Thousands to ERs

By LINDA A. JOHNSON

May 24, 2006 (AP)— Accidental overdoses and side effects from attention deficit drugs likely send thousands of children and adults to emergency rooms, according to the first national estimates of the problem.

Scientists at the U.S. Centers for Disease Control and Prevention estimated problems with the stimulant drugs drive nearly 3,100 people to ERs each year. Nearly two-thirds overdoses and accidental use could be prevented by parents locking the pills away, the researchers say.

Topics: 

US FDA approves first skin patch for ADHD

Fri Apr 7, 2006

By Susan Heavey

WASHINGTON (Reuters) - U.S. health regulators on Thursday approved the first skin patch to treat children with attention deficit hyperactivity disorder, saying it would help parents give the drug to children who have trouble taking pills.

The Daytrana patch, made by Britain's Shire Pharmaceuticals Group Plc and Noven Pharmaceuticals Inc., will deliver via the skin a generic version of one of the most popular ADHD treatments -- Swiss drug maker Novartis AG's Ritalin.

Topics: 

Panel weighs new warnings on ADHD drugs

3/22/2006

WASHINGTON (AP) — Federal health officials on Wednesday sought strengthened warnings of rare but serious risks, including heart attacks and hallucinations, associated with popular drugs for attention deficit hyperactivity disorder.

The Food and Drug Administration asked its pediatric advisory committee to review reports of those potential risks and then recommend how to relay that information to the public. The agency has struggled since last year with that latter task.

Topics: 

Feds Recommend Warnings on ADHD Drugs

By ANDREW BRIDGES,
Associated Press WriterFri Feb 10, 2006

Concerned about the risk of sudden death or serious injury associated with Ritalin and other stimulants used to treat attention deficit hyperactivity disorder, a federal advisory panel says the drugs should carry the most serious type of warning label.

Topics: 

Study: Adult Use of ADHD Medicines Doubles

By LINDA A. JOHNSON, AP Business Writer Thu Sep 15, 2005

TRENTON, N.J. - Use of prescription drugs for attention deficit hyperactivity disorder is growing at a faster rate among adults than children, new research shows.

Between 2000 and 2004, use of drugs that help keep ADHD patients focused doubled among adults aged 20 to 44, but rose only 56 percent among children, according to data compiled by Medco Health Solutions, one of the country's largest prescription benefit managers.

Topics: 

Nature Deficit

by Richard Louv

As any parent or teach probably knows, the number of children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) has skyrocketed—by 33 percent from 1997 to 2002. Prescriptions of stimulant medications such as methylphenidate (Ritalin) and amphetamines (Dexedrine) have risen as well, especially for preschoolers. From 2000 to 2003, spending on ADHD drugs for children under five rose 369 percent.

Topics: 

ADHD and Food Allergies

By Anthony Kane, MD
Introduction

There are a number of controversial areas in medicine when it comes to ADHD. Food allergy is certainly one of them.

The classic allergic reaction, which is classified as the type-1 hypersensitivity reaction, can be elicited by food, but this is fairly uncommon. When we discuss food sensitivities in ADHD we are discussing a different, not well-defined, mechanism.

Topics: